Patent · US Active

Bispecific antibodies comprising a disulfide stabilized-Fv fragment

US9879095B2 · kind B2 · utility

5Cited by

128References

19Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Ulrich Brinkmann · Weilheim, DE
Alexander Haas · Munich, DE
Silke Metz · Annaberg-Buchholz, DE
Juergen Michael Schanzer · Traunstein, DE

Key dates

Filing date	Feb 21, 2013
Grant date	Jan 30, 2018
Priority date	—
Expiry date	Feb 21, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to bispecific antibodies, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.